International Journal of Hematology

DOI: 10.1007/s12185-018-02565-y Pages: 239-240

The world’s first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells

1. The University of Tokyo, Department of Biomedical Ethics, Faculty of Medicine

2. New York University School of Medicine, Division of Medical Ethics, Department of Population Health

3. University of Washington School of Medicine, Department of Bioethics and Humanities

4. University of Johannesburg, African Centre for Epistemology and Philosophy of Science

Correspondence to:
Akira Akabayashi
Tel: +81-35841-3511



To access the full text, please Sign in

If you have institutional access, please click here

Share the Knowledge